# Alternate Dosing Schedules Study for HPV Vaccine

> **NCT00862810** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 72 (actual)

## Conditions studied

- Cervical Cancer
- Genital Warts

## Interventions

- **BIOLOGICAL:** Received HPV vaccine first
- **BIOLOGICAL:** Received concomitant vaccines first

## Key facts

- **NCT ID:** NCT00862810
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862810, "Alternate Dosing Schedules Study for HPV Vaccine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00862810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*